Iopanoic acid in the management of neonatal Graves' disease

Sonja M Earles1, Peter M Gerrits, David J Transue

  • 1Department of Pediatrics, William Beaumont Hospital, Royal Oak, MI 48073, USA.

Insights

Iopanoic acid offers a safe and effective treatment for neonatal thyrotoxicosis, significantly improving infant health. This novel approach reduces the need for frequent dosing and avoids the side effects associated with traditional therapies.

Area of Science:

  • Endocrinology
  • Neonatal Medicine
  • Pharmacology

Background:

  • Neonatal thyrotoxicosis is traditionally managed with antithyroid drugs, iodine, sedatives, and propranolol.
  • Conventional treatments for neonatal thyrotoxicosis carry risks of side effects and require frequent administration.

Purpose of the Study:

  • To evaluate the efficacy and safety of using the radio-contrast agent iopanoic acid for managing neonatal thyrotoxicosis.

Main Methods:

  • Five infants diagnosed with neonatal thyrotoxicosis were treated.
  • Initial treatment involved propranolol (1.7 mg/kg/day) combined with iopanoic acid (250-500 mg every 3-4 days).

Main Results:

  • All infants showed significant clinical improvement within 24-72 hours.
  • Thyroid hormone levels (T3 and T4) decreased dramatically.
  • No adverse toxic side effects were observed during the treatment period.

Conclusions:

  • Iopanoic acid provides a successful management strategy for neonatal thyrotoxicosis.
  • This treatment is well-tolerated, requires infrequent dosing (every 3-4 days), and maintains euthyroid status without inducing hypothyroidism.
  • Iopanoic acid presents a safer alternative to propylthiouracil (PTU), which has significant side effects and requires more frequent administration.
Abstract

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...